Found: 8
Select item for more details and to access through your institution.
Correction to: IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2020, v. 477, n. 1, p. 143, doi. 10.1007/s00428-019-02712-8
- By:
- Publication type:
- Article
Dose-dense ABVD as first-line therapy in early-stage unfavorable Hodgkin lymphoma: results of a prospective, multicenter double-step phase II study by Fondazione Italiana Linfomi.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 10, p. 2547, doi. 10.1007/s00277-021-04604-x
- By:
- Publication type:
- Article
Complete remission with brentuximab vedotin in a case of primary cutaneous gamma‐delta T‐cell lymphoma relapsed after allogeneic stem cell transplantation.
- Published in:
- International Journal of Dermatology, 2021, v. 60, n. 6, p. 778, doi. 10.1111/ijd.15393
- By:
- Publication type:
- Article
Exploratory Genome-Wide Association Analysis to Identify Pharmacogenetic Determinants of Response to R-CHOP in Diffuse Large B-Cell Lymphoma.
- Published in:
- Cancers, 2023, v. 15, n. 10, p. 2753, doi. 10.3390/cancers15102753
- By:
- Publication type:
- Article
The Role of 18F-FDG PET/CT in Staging and Prognostication of Mantle Cell Lymphoma: An Italian Multicentric Study.
- Published in:
- Cancers, 2019, v. 11, n. 12, p. 1831, doi. 10.3390/cancers11121831
- By:
- Publication type:
- Article
Nonpeghylated liposomal doxorubicin combination regimen (R‐COMP) for the treatment of lymphoma patients with advanced age or cardiac comorbidity.
- Published in:
- Hematological Oncology, 2020, v. 38, n. 4, p. 478, doi. 10.1002/hon.2764
- By:
- Publication type:
- Article
Comparison of first-line treatment with bendamustine plus rituximab versus R-CHOP for patients with follicular lymphoma grade 3A: Results of a retrospective study from the Fondazione Italiana Linfomi.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1120967
- By:
- Publication type:
- Article